DSM on the Forbes Global 2000 List #pharmaceutical #companies #in #boston

Posted On Jul 23 2017 by

#dsm pharma # #1 287 DSM Market Cap As of May 2016 $10.3 Billion Industry Diversified Chemicals Founded 1902 Country Netherlands Chief Executive Officer Feike Sijbesma Website http://www.dsm.com Employees 20 750 Sales $8.56 B Headquarters Heerlen Royal DSM NV engages in the manufacturing and sale of nutritional and pharmaceutical ingredients, and industrial chemicals. The company operates through the following segments: Nutrition, Performance Materials, Pharma, Polymer Intermediates, Innovation Center, and Corporate Activities. The Nutrition segment comprises of the DSM Nutritional Products and DSM Food Specialties business groups, which concentrate on human nutrition and animal nutrition health. The Pharma segment develops and …


How A Big Drug Company Inadvertently Got Americans Hooked On Heroin #mitsubishi #tanabe #pharma

Posted On Jul 22 2017 by

#perdue pharma # How A Big Drug Company Inadvertently Got Americans Hooked On Heroin When she was 18, Arielle would come home every day and embark on what she calls an “Easter egg hunt.” She wasn’t looking for candy. Arielle was hunting behind stairwells and inside closets in her suburban Long Island home for the OxyContin bottles her cousin brought home from work at a pharmacy and was hiding from her mother around the house. “I found them one day, and I wanted to try them because all of my friends were already hooked,” said Arielle, who asked that her …


Eli Lilly on the Forbes Global 2000 List #pharma #guidelines

Posted On Jul 13 2017 by

#lilly pharma # #243 Eli Lilly Market Cap As of May 2016 $86 Billion Ticker LLY $77,23 $-0,38 (-0,005%) Industry Pharmaceuticals Founded 1876 Country United States Chief Executive Officer John Lechleiter Website http://www.lilly.com Employees 41 275 Sales $19.96 B Headquarters Indianapolis, Indiana Eli Lilly & Co. discovers, develops, manufactures and sells pharmaceutical products. The company operates through the following business segments: Human Pharmaceutical Products and Animal Health. The Human Pharmaceutical products segment includes the discovery, development, manufacturing, marketing, and sales of human pharmaceutical products worldwide in the following therapeutic areas: neuroscience, endocrinology, oncology, cardiovascular, and other. The Animal health segment …


Sun Pharma Industries on the Forbes World’s Most Innovative Companies List #glenmark #pharma

Posted On Jul 11 2017 by

#sun pharma # #73 Sun Pharma Industries Market Cap As of May 2016 $29.7 Billion Industry Pharmaceuticals Country India Chief Executive Officer Dilip Shanghvi Website http://www.sunpharma.com Employees 30 000 Sales $4.13 B Sun Pharmaceutical Industries Ltd. manufactures and markets pharmaceutical ingredients. The company manufactures and markets a basket of pharmaceutical formulations as branded generics as well as generics in India, the United States and several other markets across the world. Sun Pharmaceutical engages in product development, process chemistry, and manufacturing of complex API, as well as dosage forms. Its products are prescribed in chronic therapy areas like cardiology, psychiatry, neurology, …


Enhanced Datasets on India’s Pharmaceutical Sector #alexion #pharma

Posted On Jul 11 2017 by

#pharmaceutical industry statistics # Enhanced Datasets on India’s Pharmaceutical Sector CEIC India Data Talk – Database Expansion Highlights: Pharmaceutical Sector Statistics – March 17, 2015 The Indian Premium Pharmaceutical Sector Statistics have been expanded to include detailed sector-wise operational indicator statistics (such as growth in sales, expenses, interest, tax and profitability) of the pharmaceutical industry. The performance of the pharmaceutical sector is further disaggregated to highlight the involvement of the public sector in this industry, in line with the government’s plan for public sector enterprises to act as a driver for self-reliant economic growth. Detailed breakdowns looking at the six …


AMA Calls for Ban on Direct to Consumer Advertising of Prescription Drugs and Medical Devices

Posted On Jul 10 2017 by

#pharmaceutical advertising # AMA News Room AMA Calls for Ban on Direct to Consumer Advertising of Prescription Drugs and Medical Devices For immediate release: Nov. 17, 2015 ATLANTA Responding to the billions of advertising dollars being spent to promote prescription products, physicians at the Interim Meeting of the American Medical Association (AMA) today adopted new policy aimed at driving solutions to make prescription drugs more affordable. Physicians cited concerns that a growing proliferation of ads is driving demand for expensive treatments despite the clinical effectiveness of less costly alternatives. Today s vote in support of an advertising ban reflects concerns …


Background on Drug Advertising #pharma #licensing

Posted On Jul 10 2017 by

#pharmaceutical advertising # Background on Drug Advertising The Food and Drug Administration (FDA) protects public health by assuring the safety, effectiveness, and security of a wide range of products, including human prescription drugs. We also advance public health by helping people get the accurate, science-based information they need to use medicines appropriately and improve their health. We serve the public health and welfare in many ways. One way is overseeing the approval and marketing of prescription drugs. Our authority is based on a number of federal laws, including the Federal Food, Drug, and Cosmetic Act. Among other areas, this law …


India – s Pharmaceutical industry is on a good growth path, but will have to

Posted On Jul 8 2017 by

#future of pharmaceutical industry # India’s Pharmaceutical industry is on a good growth path, but will have to watch out for the regulatory interventions The Indian pharma industry is on a good growth path and is likely to be in the top 10 global markets in value term by 2020. according to the PwC – CII report titled “India Pharma Inc: Gearing up for the next level of growth”. High burden of disease, good economic growth leading to higher disposable incomes, improvements in healthcare infrastructure and improved healthcare financing are driving growth in the domestic market, the report highlighted. The …


Purdue Pharma issues statement on OxyContin report; L #generic #pharmaceutical #manufacturers

Posted On Jul 8 2017 by

#purdue pharmaceutical # Purdue Pharma issues statement on OxyContin report; L.A. Times responds urdue Pharma issued a statement Friday defending its best-selling painkiller, OxyContin, and criticizing a Los Angeles Times report that the medication wears off early in many patients, exposing them to increased risk of addiction. OxyContin s main selling point is that it relieves pain for 12 hours. The Times investigation found that when the effects don t last, patients can suffer excruciating symptoms of narcotic withdrawal, including intense craving for the drug. The article said that Purdue had held fast to 12-hour dosing in part for financial …